October 2, 2024
[10-2-2024] FDA continues to advise consumers not to purchase or use Body Shape Weight Loss System, a product promoted and sold for weight loss. This product […]
October 2, 2024
TOPLINE: Adjuvant chemotherapy after removal of the affected eye improves outcomes in children with unilateral retinoblastoma who have high-risk histopathologic features that predispose them to metastases […]
October 2, 2024
Compounding drugs when the drug is in shortage FDA understands that when a drug is in shortage, patients and health care professionals may look to compounded […]
October 2, 2024
TOPLINE: Women with premature ovarian insufficiency (POI) have a 2.6 times higher prevalence of severe autoimmune diseases before diagnosis and a 2- to 3-fold increased risk […]
October 2, 2024
The table below lists all the documents and supportive files applicable to eCTD submissions to CDER and CBER. Version History Submission Standards for eCTD v4.0 Validation […]
October 2, 2024
Approved Drugs: Questions and Answers How is medicine approved by FDA? How can I find out if my medicine is approved by FDA? How can I […]
October 2, 2024
People with hidradenitis suppurativa (HS) who have overweight or obesity may benefit from adjunctive treatment with the glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Ozempic, Wegovy), […]
October 2, 2024
On This Page Date: November 6 – 7, 2024 Day1: Wed, Nov 6 8:30 AM – 5:30 PM ET Day2: Thu, Nov 7 8:30 AM – […]
October 2, 2024
TOPLINE: Over 90% of patients with symptoms of bronchitis, sinus infections, sore throats, colds or flu, or diarrhea expect antibiotic prescriptions. Visiting a public clinic, lower […]